Fastenal Company Common Stock vs Eli Lilly And Co — how do they compare? Fastenal Company Common Stock trades at $50.81 (market cap $57.94B), while Eli Lilly And Co trades at $1,175 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 17.9× Fastenal Company Common Stock's market cap, and Fastenal Company Common Stock pays the higher dividend (1.9%). Which is the better fit depends on your goals — on Pluang, investors hold Fastenal Company Common Stock for 1 Days and Eli Lilly And Co for 93 Days on average.
| FAST | LLY | |
|---|---|---|
Market Cap | $57.94B | $1.04T |
Volume | 6,764,575 | 3,064,878 |
Sector | Industrials | Health |
52-Week High | $52.38 | $1.28K |
52-Week Low | $39.15 | $799.57 |
Typical Hold Time | 1 Days | 93 Days |
Enterprise Value | $58.17B | $1.09T |
Dividend Yield | 1.9% | 0.59% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.
Read more on FAST →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →